Variables | Grade 3–4 postoperative complications | |||
---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
OR(95%CI) | P | OR(95%CI) | P | |
Gender: male/female | 1.45 (0.55–3.83) | 0.456 |  |  |
Age at operation | 1.02 (0.98–1.07) | 0.347 |  |  |
ASA score (I-II/III-IV) | 1.47 (0.48–4.50) | 0.499 |  |  |
Body mass index | 1.08 (0.90–1.28) | 0.342 |  |  |
Preoperative chemotherapy (no/yes) | 1.76 (0.52–5.92) | 0.360 |  |  |
Site of original (colon/rectum) | 2.47 (0.88–7.0) | 0.087 |  |  |
Liver metastases (no/yes) | 1.28 (0.40–4.14) | 0.687 |  |  |
HIPEC regimen (lobaplatin/non-lobaplatin) | 0.48 (0.17–1.40) | 0.177 |  |  |
Operative time | 1.01 (0.99–1.01) | 0.164 |  |  |
Estimated blood loss | 1.62 (1.21–2.04) | < 0.001 | 1.41 (1.13–1.82) | < 0.001 |
Presence of ascites (no/yes) | 1.14 (0.43–3.03) | 0.790 |  |  |
PCI score | 1.12 (1.03–1.20) | 0.008 | 1.22 (0.95–1.44) | 0.085 |
CC score (0–1/2–3) | 0.76 (0.28–2.05) | 0.582 |  |  |